Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Apr;170(2):55-64.
doi: 10.1016/j.molbiopara.2009.12.004. Epub 2009 Dec 23.

Phospholipid and sphingolipid metabolism in Leishmania

Affiliations
Review

Phospholipid and sphingolipid metabolism in Leishmania

Kai Zhang et al. Mol Biochem Parasitol. 2010 Apr.

Abstract

In many eukaryotes, phospholipids (PLs) and sphingolipids (SLs) are abundant membrane components and reservoirs for important signaling molecules. In Leishmania, the composition, metabolism, and function of PLs and SLs differ significantly from those in mammalian cells. Although only a handful of enzymes have been experimentally characterized, available data suggest many steps of PL/SL metabolism are critical for Leishmania viability and/or virulence, and could be a source for new drug targets. Further studies of genes involved in the synthesis (de novo and salvage) and degradation of PLs and SLs will reveal their diverse effects on Leishmania pathogenesis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
PLs and SLs in L. major. (A) Lipid composition in L. major promastigotes based on the headgroups (left) or anchors (right) of PLs. Structures of each class of lipids were determined by ESI/MS/MS and abundance was estimated as previously described [22, 23, 26]. Other PLs include phosphatidylglycerol (PG), cardiolipin (CL), and phosphatidic acid. (B)–(F) Molecular species of PE and SLs in L. major. (B) A PLE: 1-O-octadec-1’-enyl 2-octadecenoyl sn-glycero-3-phosphoethanolamine (p18:0/18:1-PE). (C) A diacyl PE: 1,2-distearoyl sn-glycero-3-phosphoethanolamine (18:0/18:0-PE). (D) A lyso-PE: 1-O-octadec-1’-enyl 2-lyso sn-glycero-3-phosphoethanolamine (p18:0/lyso-PE). (E) A ceramide: N-stearoylhexadecesphing-4-enine (d16:1/18:0-Cer). (F) An IPC: phosphoryl inositol N-stearoylhexadecesphing-4-enine (d16:1/18:0-IPC).
Figure 2
Figure 2
Predicted metabolism of SLs and PLs in Leishmania. DAG: diacylglycerol; G-3-P: glycerol-3-phosphate; DHAP: dihydroxyacetonephosphate. Enzymes of which candidate genes have been identified in the L. major geneDB are indicated. Gray dotted arrows represent pathways where the putative enzymes have yet to be identified. Experimentally characterized enzymes/genes (circled) include DAT (dihydroxyacetone phosphate acyltransferase, system ID: LmjF34.1090), GAT (glycerol-3-phosphate acyltransferase, LmjF03.0080), ADS1 (1-alkyl dihydroxyacetone phosphate synthase 1, LmjF30.0120), G3PD (glycerol-3-phosphate dehydrogenase, LmjF10.0510), SPT (serine palmitoyltransferase, LmjF34.3740 and LmjF35.0320), SPL (sphingosine-1-phosphate lyase, LmjF30.2350), IPCS (IPC synthase, LmjF35.4990), and ISCL (inositol sphingolipidphospholipase C-like, LmjF08.0200). Other enzymes (that have yet to be characterized although their putative genes have been identified from L. major genome) include CS (ceramide synthase); CD (ceramidase); SK (sphingosine kinase); E/CK (ethanolamine/choline kinase); EPCT (ethanolamine-phosphate cytidylyltransferase); CPCT (cholinephosphate cytidylyltransferase); EPT (ethanolamine-specific phosphotransferase); C/EPT (choline/ethanolamine phosphotransferase); BE: (base exchange enzyme or PS synthase); and PSD (PS decarboxylase).
Figure 3
Figure 3
SL-null L. major generates normal DRM rafts. (A) TX100 insoluble (I) and soluble (S) fractions from log phase parasites (WT and spt2) were analyzed by western-blot to assess the distribution of gp63, gp46, and glucose transporter (GT). (B) Log phase WT and spt2 parasites were labeled with [1,2]14C-acetate and extracted with 1% TX100 at 4 °C or 37 °C. Detergent insoluble materials were separated from soluble materials by centrifugation. Lipids from both insoluble and soluble fractions were extracted and analyzed by thin layer chromatography. Ergo: ergosterol; PLs: phospholipids. (C) WT and spt2 parasites with episomally expressed HASPB-GFP or FCaBP-HA were subjected to detergent extraction and western-blot analysis as described in (A), using anti-GFP and anti-HA antibodies. In addition, these parasites were subjected to fluorescence microscopy, as shown in D (GFP epifluorescence) and E (primary antibody: anti-HA mAb; secondary antibody: FITC-labeled goat-antimouse IgG). Leishmania culture, DRM isolation, and western-blot were performed as previously described [27]. To isolate metacyclics, spt2 mutants were grown to stationary phase in the presence of 500 µM of EtN as previously described [23].
Figure 4
Figure 4
2D gel analysis of DRM fraction in L. major. DRM fractions were prepared from log phase WT and spt2 parasites as described [27] and subjected to 2D gel electrophoresis. Among all detectable spots, only ~1.2% showed greater than 2.5-fold variation between WT and spt2.

Similar articles

Cited by

References

    1. Majerus PW, et al. The metabolism of phosphoinositide-derived messenger molecules. Science. 1986;234:1519–1526. - PubMed
    1. Rhee SG. Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem. 2001;70:281–312. - PMC - PubMed
    1. Chakraborti S. Phospholipase A(2) isoforms: a perspective. Cell Signal. 2003;15:637–665. - PubMed
    1. Divecha N, Irvine RF. Phospholipid signaling. Cell. 1995;80:269–278. - PubMed
    1. Coppolino MG, et al. Inhibition of phosphatidylinositol-4-phosphate 5-kinase Ialpha impairs localized actin remodeling and suppresses phagocytosis. J Biol Chem. 2002;277:43849–43857. - PubMed

Publication types

LinkOut - more resources